Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
Why is 2026 already a record year for M&A activity?
Regulation & Industry
Why is 2026 already a record year for M&A activity?
Blockbuster acquisitions are back, impacting the pharma industry at record pace. As billions flow into breakthrough science, LSIPR’s series explores what’s driving the surge, how today’s deals are done, and where IP comes into the picture.   17 July 2026
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification patents, seeking damages from vaccines worth billions.   15 July 2026
UK-Switzerland strike trade deal with first-of-its-kind pharma rules
Regulation & Industry
UK-Switzerland strike trade deal with first-of-its-kind pharma rules
An enhanced agreement between the two countries cements existing protections for pharma innovators and is being hailed by the industry as a boost for investment and research.   14 July 2026
Pharma
Exelixis opens two-front patent dispute over Cabometyx copies
Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.   9 July 2026
Pharma
Influential Women in IP 2026: Who made the list?
Leading women from the pharmaceutical and biotechnology sectors are among the more than 100 professionals recognised in a newly released Influential Women in IP 2026 list, which celebrates leadership, expertise and innovation.   7 July 2026
Biotech
LSD trade secrets suit over clinical trail info thrown out by judge
A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.   2 July 2026
Careers
HGF expands European offering with pair of in-house hires
The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.   2 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
Otsuka v Sun Pharma could redefine which pharmaceutical patents qualify for patent term extensions, with major implications for innovator companies, generic manufacturers and the future of market exclusivity in the country.   1 July 2026
Pharma
Will Mounjaro and Zepbound get their first US generic rival?
Sandoz has filed FDA applications for generic versions of Eli Lilly’s blockbuster drugs, marking an early step towards potential competition in the fast-growing GLP-1 market.   30 June 2026
Regulation & Industry
Ashurst Perkins Coie opens its doors following landmark merger
The newly combined transatlantic firm brings together more than 950 partners across 20 countries, uniting leading patent, trade secrets, life sciences, and tech practices.   29 June 2026